Pursuing Excellence in Xeno, Shaping Swine into Life-Giving Vessels, Sowing Blessings Across Humanity

Pursuing Excellence in Xeno, Shaping Swine into Life-Giving Vessels, Sowing Blessings Across Humanity

Millions wait for transplants — together, we can bring hope to life

Millions wait for transplants — together, we can bring hope to life

What is Xenotransplantation?

Concept

Transplanting animal-derived organs, tissues, or cells into humans


Types

Solid organs (e.g., kidney, liver, heart), biological tissues, and cellular therapies


Core Value

Addressing the critical global shortage of transplantable human organs

What is Xenotransplantation?
Why Choose Pigs for Xenotransplantation?

Pigs are considered ideal organ donors for xenotransplantation

  • Comparable organ size, and physiological compatibility with humans

  • High genetic tractability and rapid reproductive cycle

  • Lower ethical concerns compared to non-human primates, with manageable risk of zoonotic disease transmission

  • Well-established husbandry practices ensure a stable and reliable medical-grade organ supply

Why Choose Pigs for Xenotransplantation?
About ClonOrgan
China's Leading Xenotransplantation Enterprise

ClonOrgan is long-term dedicated to the in-depth R&D of xenotransplantation donor pigs;

Cultivating China's largest population of gene-edited, low-immunogenicity donor pigs;

Developing therapeutic technologies using transplantable pig organs and tissues, including kidneys, livers, hearts, skin, red blood cells.

  • Professor Dengke Pan

    Professor Dengke Pan

  • Professor Shaoping Deng

    Professor Shaoping Deng

News
Company News
Media Coverage
Science Outreach
Science Literature
  • 中科奥格基因编辑猪助力全球首例异种原位全肝移植研究登上顶刊

    2026/09/17 Company News
    企业新闻2026年9月16日,中科奥格与西京医院窦科峰院士团队合作的全球首例基因编辑猪-脑死亡人受试者异种原位全肝移植研究论文“Orthotopic Liver Xenotransplantation from Gene-Modified Pig to Decedent Human ”正式在Nature Biomedical Engineering期刊发表,中科奥格董事长潘登科研究员为论...
  • 欧洲考察续篇 | 中科奥格巴黎行:锚定全链条布局,推进异种移植中欧国际合作

    2026/09/13 Company News
    作为荷兰莱顿考察的延续,9月9~10日,中科奥格联合创始人邓绍平教授、首席医疗官Leo Bubler及副总经理尹璐一行继续赴法国巴黎开展学术交流和合作考察。考察团队参加了由《Nature》主办的“人工智能时代重塑医疗”国际会议,围绕AI、多组学技术如何赋能异种移植精准诊疗,与参会专家展开交流。团队认为,AI与多组学等前沿技术,有望为异种移植的精准诊断、术后监测和排斥反应分析提供新的思路与工具。▲ ...